Eric Rojas News Today

FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One ...

/PRNewswire/ -- Batteries Plus, the worlds leading specialty battery franchise, is proud to announce the launch of its first-ever national B2B campaign,...

Bad Bunny's Most Wanted tour touched down at Barclays Center in New York on Thursday night (April 11); here are the five best moments from the show.

Go-to speed sessions that will help you run stronger, build mental toughness, and improve your PR.

The California International Marathon was the final race to qualify for the 2024 Olympic Marathon Trials, which will take place on February 3 in Orlando.

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Analysis of 72 patients treated in STK-001 clinical trials suggests that higher...

From Becky G's Coachella fit to RBD's iconic Elite Way uniform, check out some easy DIY Halloween costumes to dress as your favorite Latin star.

BEDFORD, Mass., October 17, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on October 16th, 2023, the company granted a stock option to purchase an aggregate of 32,800 shares of common stock to 1 new employee, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating prote...

DUBLIN--(BUSINESS WIRE)--Sep 5, 2023--